BRCA, the Oviduct, and the Space and Time Continuum of Pelvic Serous Carcinogenesis
- 1 May 2012
- journal article
- research article
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 22 (S1), S29-S34
- https://doi.org/10.1097/igc.0b013e31824d7269
Abstract
In recent years, the distal oviduct has emerged as a critical organ in the pathogenesis of pelvic (“ovarian”) serous cancer. Studies have uncovered early serous tubal intraepithelial carcinomas in approximately 8% of asymptomatic women with germline BRCA1 or BRCA2 mutations, linked serous tubal intraepithelial carcinomas to one half of serous cancers irrespective of genetic risk, and described a precursor lesion in the distal tube with early alterations in p53 function (the p53 signature). This work has established a linear serous carcinogenic sequence in a single focus within the fimbria. In addition, a more broadly distributed array of gene alterations has been discovered in the oviduct, manifested as secretory (or stem) cell outgrowths that are increased in frequency as a function of older age and serous cancer status. These “surrogate precursors” expand the existing model beyond the fimbria, implying that the molecular events leading to serous cancer are distributed over space and time. The potential promise of these discoveries is “targeted prevention” by discovering of multiple pathways integral to carcinogenesis and successfully preventing malignancy by interrupting one or a few of these pathways.Keywords
This publication has 41 references indexed in Scilit:
- Intercepting pelvic cancer in the distal fallopian tube: Theories and realitiesMolecular Oncology, 2009
- The incidence of primary fallopian tube cancer in the United StatesGynecologic Oncology, 2007
- Incidental Carcinomas in Prophylactic Specimens in BRCA1 and BRCA2 Germ-line Mutation Carriers, With Emphasis on Fallopian Tube LesionsThe American Journal of Surgical Pathology, 2006
- Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriersGynecologic Oncology, 2006
- Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult MalignancyJournal of Clinical Oncology, 2005
- Cancer of the OvaryThe New England Journal of Medicine, 2004
- Ovarian TumorigenesisThe American Journal of Pathology, 2004
- Pathologic Findings in Prophylactic Oophorectomy Specimens in High-Risk WomenGynecologic Oncology, 2002
- Occult Carcinoma in Prophylactic Oophorectomy SpecimensThe American Journal of Surgical Pathology, 2001
- Incidence of malignant fallopian tube tumorsGynecologic Oncology, 1989